Literature DB >> 4758050

Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.

M C Bach, O Gold, M Finland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4758050     DOI： 10.1093/infdis/128.supplement_3.s584

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

1.  Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Authors:  Brittany L Murray; Christine M Murphy; Michael C Beuhler
Journal:  J Med Toxicol       Date:  2012-03

2.  General survey of trimethoprim combinations in the treatment of urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Co-trimoxazole or trimethoprim alone? A viewpoint on their relative place in therapy.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

4.  Infections in cerebrospinal fluid shunts.

Authors:  P Upadhyaya
Journal:  Indian J Pediatr       Date:  1985 Jul-Aug       Impact factor: 1.967

Review 5.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

6.  Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors:  F Andreasen; L Elsborg; S Husted; O Thomsen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

7.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

8.  Intrarenal distribution of trimethoprim and sulfamethoxazole.

Authors:  S Trottier; M G Bergeron; C Lessard
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

9.  Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.

Authors:  J Y Chatton; A Munafo; J P Chave; F Steinhäuslin; F Roch-Ramel; M P Glauser; J Biollaz
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

10.  Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.

Authors:  W E Grose; G P Bodey; T L Loo
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.